posted
this one is about to take off again! 95 mill OS and 200 mill AS with patents pending on new adult stem cell technique!!
look for a major bounce for CLBE,the 10-Q next month should be the best they ever had and rumor has it the microbank has opened so a PR should be hitting anytime! Could run into the low teens again!
This is from the last shareholder release; However, the study shows CalbaTech had the second lowest market capitalization. "We believe this means that CalbaTech has tremendous stock upside potential. If our revenues and profits begin to reach pro-forma projections, particularly with LifeStem's Stem Cell MicroBank(TM) Service to open this month, the stock price should respond accordingly," wrote James DeOlden, CEO. The entire letter follows:
posted
Hit .04 but watch it close,look for an EOD rally because many feel good about this week and may close near .08's imo.This runs to the teens fast so get ready.
posted
Great call, Quest. The MMs have collected tons of shares, and it will have a huge run.
Posts: 3228 | From: Michigan | Registered: Aug 2005
| IP: Logged |
posted
well didnt this usually run on the 10-q than anything else? Would it not be best to wait till 10-q is near
Posts: 1088 | From: Dallas, Texas | Registered: Feb 2006
| IP: Logged |
posted
I just wish we could edit titles on Allstocks...
either way CLBE I believe is heading back into the double digits again and may end up staying there this time.I think some SCLL investors have started moving into this because of the last SCLL DEF14 filing and CLBE is a far better investment imo.
posted
THIS MONTH is only 2 days left and I hope they don't PR anything on Friday unless its before open and any statement like this has to be given some serious consideration as to the true value of the management of this company......
First Quarter 2006 Financial Results/Stock Performance
The first quarter of this year is reflective of our belief in the CalbaTech model, as well as the actions we have taken over the past year. KD Medical, Molecula, and another of our other wholly-owned subsidiaries, Molecularware, Inc., all were profitable and as a whole experienced a 25% growth in revenue. LifeStem is primed for success as the pricing and cost structure of the Stem Cell Microbank(TM) Service will be profitable from each collection. Recently, an industry source published information regarding each of the public companies competing in the stem cell arena. Of the sixteen companies listed, CalbaTech was listed third in EBITDA (Earnings Before Income Taxes, Depreciation and Amortization), and first in average daily trading volume, yet had the second lowest market capitalization. We believe this means that CalbaTech has tremendous stock upside potential. If our revenues and profits begin to reach our pro-forma projections, particularly with LifeStem's Stem Cell MicroBank(TM) [COLOR="Red"]Service set to open in June, the price of our stock should respond accordingly.[/COLOR]
We have put the building blocks in place and have begun building a truly successful company. We are pleased that you have chosen to invest in CalbaTech. Thank you for the trust and continued support.
posted
MMs have the ability to run it without PR, if they get enough cheap shares. Last run was done without a pr. They used to PR to trap investors. It happened five times in the last two months. See the chart, and you will find out a pr is not a good time to get in.
Posts: 3228 | From: Michigan | Registered: Aug 2005
| IP: Logged |
posted
I disagree Jim.....a PR on the opening of the microbankl (that will already open in the profits) will confirm the clear direction of the company and read the share holders letter on the 13th. Check out the site for CLBE...
posted
I think in all seriousness that the next break out for CLBE will eventually send us into the .20's and thats nots just a guess,I base it on the company and the history and whats coming up for them and the industry altogether....this is a big deal in the works and if anyone here is invested in STEM or SCLL you may want to invest a lot more here,just look at the other stocks and compare what they have and take a serious look at just exactly whay CLBE has.
I hope it will have 2-week run, slow but steady. The new SEC rule will make MMs' manipulation more difficult. So they will maximize their profit by pushing pps higher. I still expect a 5X in 6 weeks.
posted
well its not taking off yet thats why i said yesterday that, it was probably best to buy close to earnings. by the way XKEM is moving
Posts: 1088 | From: Dallas, Texas | Registered: Feb 2006
| IP: Logged |
posted
I totally disagree stocks and if this breeches .043 you can expect it to hit .055 quick imo.As for XKEM did you call the transfer agent recently? if not you may want to do so.
posted
quest, i remember you from ************** board, you suprise me every time. Good call, wish i would have got in at .039
Posts: 1088 | From: Dallas, Texas | Registered: Feb 2006
| IP: Logged |
posted
stocks here an opinion from a pro chartist I deal with.
OK breakout nowwwwwwww.........I jumped on bid took out the .044s!!!! Arca orders filling book box now..... NO big sellers to .08 we will see short opposition around .055 and a squeeze past .06!!!
I am more conservative and see a slight retrace around mid .05's but I also see this eventually heading to the .20's in the near future...believe me its overdue.
posted
just by looking at the chart, it has been on a steadily decline and when it attempts to break out off the top bollinger band it bounces and heads back down. thats my only worry. but i might buy here if i strongly feel we could see double from these levels
Posts: 1088 | From: Dallas, Texas | Registered: Feb 2006
| IP: Logged |
quote:Originally posted by stocks1984: well its not taking off yet thats why i said yesterday that, it was probably best to buy close to earnings. by the way XKEM is moving
All otc stock trading is a form of gamble. The chance of getting 5X in 6 weeks, if you take a position now for:
a. CLBE: 75% (0.04 5X will be 0.20) b. XKEM: 2% (0.062 5X will be 0.31)
So, this is my gamble. You have to play yours. Just play on paper and see who is right or closer in 6 weeks. I agree with Quest on this one.
Posts: 3228 | From: Michigan | Registered: Aug 2005
| IP: Logged |
also any CEO that can inform share holders like this I will gladly invest in.
First Quarter 2006 Financial Results/Stock Performance
The first quarter of this year is reflective of our belief in the CalbaTech model, as well as the actions we have taken over the past year. KD Medical, Molecula, and another of our other wholly-owned subsidiaries, Molecularware, Inc., all were profitable and as a whole experienced a 25% growth in revenue. LifeStem is primed for success as the pricing and cost structure of the Stem Cell Microbank(TM) Service will be profitable from each collection.
Recently, an industry source published information regarding each of the public companies competing in the stem cell arena. Of the sixteen companies listed, CalbaTech was listed third in EBITDA (Earnings Before Income Taxes, Depreciation and Amortization), and first in average daily trading volume, yet had the second lowest market capitalization. We believe this means that CalbaTech has tremendous stock upside potential. If our revenues and profits begin to reach our pro-forma projections, particularly with LifeStem's Stem Cell MicroBank(TM) Service set to open in June, the price of our stock should respond accordingly.
We have put the building blocks in place and have begun building a truly successful company. We are pleased that you have chosen to invest in CalbaTech. Thank you for the trust and continued support.
UBBFriend: Email this page to someone!
Printer-friendly view of this topic
